Merck & Co Inc
-
Pics News
FDA approves Merck’s drug for rare, deadly lung condition
[ad_1] The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening…
Read More » -
Business
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know
[ad_1] Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid. Now, the company is betting…
Read More » -
Health News
Viking stock doubled Tuesday. Here’s where the next moves in the obesity space could come from
[ad_1] Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and…
Read More » -
Health News
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
[ad_1] Blood sample of patient positive tested for sickle cell. Kitsawet Saethao | Istock | Getty Images The approval of…
Read More » -
Health News
Moderna stock jumps 15% after company posts surprise quarterly profit even as Covid vaccine sales plunge
[ad_1] Nikos Pekiaridis | Nurphoto | Getty Images Shares of Moderna jumped more than 15% on Thursday after the company…
Read More » -
Health News
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
[ad_1] Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer…
Read More » -
Business
Biden administration’s Medicare drug price negotiations will face major tests in 2024
[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services…
Read More » -
Business
Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says
[ad_1] An exterior view of Moderna’s clinical manufacturing facility. David L. Ryan | Boston Globe | Getty Images Moderna and…
Read More » -
Business
Pfizer shares fall as 2024 revenue and profit forecast disappoints
[ad_1] Shares of Pfizer fell Wednesday after the drugmaker forecast 2024 revenue and profit below Wall Street’s expectations, as it…
Read More » -
Health News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
[ad_1] Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021.…
Read More »